BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33777727)

  • 1. Characteristics of T-Cell Receptor Repertoire and Correlation With
    Yang H; Wang Y; Jia Z; Wang Y; Yang X; Wu P; Song Y; Xu H; Gu D; Chen R; Xia X; Bing Z; Gao C; Cao L; Li S; Cao Z; Liang N
    Front Oncol; 2021; 11():537735. PubMed ID: 33777727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of T cell receptor repertoire in patients with
    Wang Y; Peng L; Zhao M; Xiong Y; Xue J; Li B; Huang Z; Liu X; Yang X; Song Y; Bing Z; Guo C; Tian Z; Gao C; Cao L; Cao Z; Li J; Jiang X; Si X; Zhang L; Li X; Zheng Z; Song M; Chen R; Lim WT; Pavan A; Romero A; Liang N; Yang H; Li S
    Transl Lung Cancer Res; 2022 Sep; 11(9):1936-1950. PubMed ID: 36248331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
    Miyauchi E; Matsuda T; Kiyotani K; Low SK; Hsu YW; Tsukita Y; Ichinose M; Sakurada A; Okada Y; Saito R; Nakamura Y
    Cancer Sci; 2019 Mar; 110(3):867-874. PubMed ID: 30582659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4
    Zhu W; Germain C; Liu Z; Sebastian Y; Devi P; Knockaert S; Brohawn P; Lehmann K; Damotte D; Validire P; Yao Y; Valge-Archer V; Hammond SA; Dieu-Nosjean MC; Higgs BW
    Oncoimmunology; 2015 Dec; 4(12):e1051922. PubMed ID: 26587322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.
    Zhang L; Cham J; Paciorek A; Trager J; Sheikh N; Fong L
    BMC Bioinformatics; 2017 Feb; 18(1):129. PubMed ID: 28241742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of T cell receptor repertoire in penile cancer.
    Zhang J; Wang Y; Huang Y; Tan X; Xu J; Yan Q; Tan J; Zhang Y; Zhang J; Ma Q; Zhu H; Ye J; Zhu Z; Lan W
    Cancer Immunol Immunother; 2024 Jan; 73(2):24. PubMed ID: 38280010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR repertoire intratumor heterogeneity of CD4
    Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
    Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
    Chang YL; Wu CT; Lin SC; Hsiao CF; Jou YS; Lee YC
    Clin Cancer Res; 2007 Jan; 13(1):52-8. PubMed ID: 17200338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.
    Liu YY; Yang QF; Yang JS; Cao RB; Liang JY; Liu YT; Zeng YL; Chen S; Xia XF; Zhang K; Liu L
    Int J Cancer; 2019 Sep; 145(5):1423-1431. PubMed ID: 30664810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jinfukang inhibits lung cancer metastasis by regulating T cell receptors.
    Luo B; Wang P; Tian J; Chu X; Lu X; Yang Y; Zhou Y; Li Y; Que Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116885. PubMed ID: 37422099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer.
    Yang XR; Pi C; Zhang YC; Chen ZH; Zhang XC; Zhu DQ; Yang LL; Yin JC; Deng JY; Yang MY; Luo WC; Wu YL; Zhou Q
    Mol Carcinog; 2023 Jul; 62(7):1001-1008. PubMed ID: 37067398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the epidermal growth factor receptor mutation status and differences among molecular subgroups in surgically resected lung microinvasive adenocarcinoma.
    Li M; Li C; Ke L; Zhan M; Cheng M
    Oncol Lett; 2018 Dec; 16(6):7057-7067. PubMed ID: 30546439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiles and tumor immune microenvironment of primary lung carcinoma and brain oligo-metastasis.
    Song Z; Yang L; Zhou Z; Li P; Wang W; Cheng G; Chen R; Chang L; Zhang Y; Guan Y; Xia X; Yi X; Zhou R; Chen M
    Cell Death Dis; 2021 Jan; 12(1):106. PubMed ID: 33479213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients.
    Muraro E; Del Ben F; Turetta M; Cesselli D; Bulfoni M; Zamarchi R; Rossi E; Spazzapan S; Dolcetti R; Steffan A; Brisotto G
    Front Oncol; 2022; 12():983887. PubMed ID: 36081561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers.
    Korn S; Wiewrodt R; Walz YC; Becker K; Mayer E; Krummenauer F; Buhl R
    Am J Respir Cell Mol Biol; 2005 Feb; 32(2):142-8. PubMed ID: 15539458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients.
    Khunger A; Rytlewski JA; Fields P; Yusko EC; Tarhini AA
    Oncoimmunology; 2019; 8(11):e1652538. PubMed ID: 31646098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated recombinant human granulocyte colony-stimulating factor regulates the immune status of patients with small cell lung cancer.
    Sun J; Bai H; Wang Z; Duan J; Li J; Guo R; Wang J
    Thorac Cancer; 2020 Mar; 11(3):713-722. PubMed ID: 32020764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR Repertoire Diversity of Peripheral PD-1
    Han J; Duan J; Bai H; Wang Y; Wan R; Wang X; Chen S; Tian Y; Wang D; Fei K; Yao Z; Wang S; Lu Z; Wang Z; Wang J
    Cancer Immunol Res; 2020 Jan; 8(1):146-154. PubMed ID: 31719056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.
    Sasaki H; Endo K; Takada M; Kawahara M; Kitahara N; Tanaka H; Okumura M; Matsumura A; Iuchi K; Kawaguchi T; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Lung Cancer; 2006 Oct; 54(1):103-8. PubMed ID: 16890322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.